Penetration of didanosine in semen of HIV-1-infected men

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 6, 2006, Pages 1244-1247

  Cruciani, Mario ^a   Liuzzi, G ^b   Chirianni, A ^c   Audagnotto, S ^d   Bonora, S ^d   Di Biagio, A ^e   Sinicco, A ^d   Bassetti, M ^e   Gatti, G ^e  

^a Center of Preventive Medicine   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiretroviral therapy; Drug distribution; Pharmacokinetics; Sanctuary site

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG PENETRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SEMEN ANALYSIS; SEMINAL PLASMA; TIME; BLOOD; CHEMISTRY; METABOLISM; MIDDLE AGED; SPERM;

ADULT; ANTI-HIV AGENTS; DIDANOSINE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SEMEN;

EID: 33749183743     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl111     Document Type: Article

References (14)

1. Reddy YS, Kashuba A, Gerber J et al. Roundtable participants, forum for collaborative HIV research. Roundtable report: Importance of antiretroviral drug concentrations in sanctuary sites and viral reservoirs. AIDS Res Hum Retroviruses 2003; 19: 167-76.
2. Taylor S, Boffito M, Vernazza PL. Antiretroviral therapy to reduce the sexual transmission of HIV. J HIV Ther 2003; 8: 55-66.
3. Chun TW, Fauci AS. Latent reservoirs of HIV: Obstacles to the eradication of virus. Proc Natl Acad Sci USA 1999; 96: 10958-61.
4. Vernazza PL, Troiani L, Flepp MJ et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal sheding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14: 117-21.
5. Eron JJ, Vernazza PL, Johnston DM et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission. AIDS 1998; 12: F181-9.
6. Taylor S, Pereira AS. Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect 2001; 77: 4-11.
7. Taylor S, Back DJ, Drake SM et al. Antiretroviral drug concentrations in semen of HIV-infected men: Differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother 2001; 48: 351-4.
8. Ghosn J, Chaix ML, Peytavin G et al. Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. AIDS 2004; 18: 1958-61.
9. van Praag RM, van Heeswijk RP, Jurriaans S et al. Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1. Clin Infect Dis 2001; 33:e91-2.
10. Huang Y, Zurlinden E, Lin E et al. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous determination of didanosine and stavudine in human plasma, bronchoalveolar lavage fluid, alveolar cells, peripheral blood mononuclear cells, seminal plasma, cerebrospinal fluid and tonsil tissue. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 799: 51-61.
11. Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, April 7, 2005. http://AIDSinfo.nih.gov (13 July 2005, date last accessed).
12. Taylor S, van Heeswijk RP, Hoetelmans RM et al. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS 2000; 14: 1979-84.
13. Pereira AS, Smeaton LM, Gerber JG et al. The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850). J Infect Dis 2002; 186: 198-204.
14. van Praag RM, Weverling GJ, Portegies P et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS 2000; 14: 1187-94.